Ferreira Vera Christina Camargo de Siqueira, Etchebehere Elba Cristina Sá de Camargo, Bevilacqua José Luiz Barbosa, de Barros Nestor
MD, PhD, Hospital Sírio Libanês and Instituto do Câncer do Estado de São Paulo (Icesp), São Paulo, SP, Brazil.
MD, PhD, Faculdade de Ciências Médicas da Universidade Estadual de Campinas (FCM-Unicamp), Campinas, SP, Brazil.
Radiol Bras. 2018 Mar-Apr;51(2):87-94. doi: 10.1590/0100-3984.2017.0025.
To evaluate suspicious amorphous calcifications diagnosed on full-field digital mammography (FFDM) and establish correlations with histopathology findings.
This was a retrospective study of 78 suspicious amorphous calcifications (all classified as BI-RADS 4) detected on FFDM. Vacuum-assisted breast biopsy (VABB) was performed. The histopathological classification of VABB core samples was as follows: pB2 (benign); pB3 (uncertain malignant potential); pB4 (suspicion of malignancy); and pB5 (malignant). Treatment was recommended for pB5 lesions. To rule out malignancy, surgical excision was recommended for pB3 and pB4 lesions. Patients not submitted to surgery were followed for at least 6 months.
Among the 78 amorphous calcifications evaluated, the histopathological analysis indicated that 8 (10.3%) were malignant/suspicious (6 classified as pB5 and 2 classified as pB4) and 36 (46.2%) were benign (classified as pB2). The remaining 34 lesions (43.6%) were classified as pB3: 33.3% were precursor lesions (atypical ductal hyperplasia, lobular neoplasia, or flat epithelial atypia) and 10.3% were high-risk lesions. For the pB3 lesions, the underestimation rate was zero.
The diagnosis of precursor lesions (excluding atypical ductal hyperplasia, which can be pB4 depending on the severity and extent of the lesion) should not necessarily be considered indicative of underestimation of malignancy. Suspicious amorphous calcifications correlated more often with precursor lesions than with malignant lesions, at a ratio of 3:1.
评估在全视野数字乳腺摄影(FFDM)上诊断出的可疑无定形钙化,并与组织病理学结果建立相关性。
这是一项对在FFDM上检测到的78例可疑无定形钙化(均分类为BI-RADS 4)的回顾性研究。进行了真空辅助乳腺活检(VABB)。VABB核心样本的组织病理学分类如下:pB2(良性);pB3(恶性潜能不确定);pB4(怀疑恶性);pB5(恶性)。建议对pB5病变进行治疗。为排除恶性,建议对pB3和pB4病变进行手术切除。未接受手术的患者至少随访6个月。
在评估的78例无定形钙化中,组织病理学分析表明8例(10.3%)为恶性/可疑(6例分类为pB5,2例分类为pB4),36例(46.2%)为良性(分类为pB2)。其余34例病变(43.6%)分类为pB3:33.3%为前驱病变(非典型导管增生、小叶瘤变或扁平上皮异型增生),10.3%为高危病变。对于pB3病变,低估率为零。
前驱病变(不包括非典型导管增生,根据病变的严重程度和范围其可能为pB4)的诊断不一定意味着对恶性的低估。可疑无定形钙化与前驱病变的相关性比与恶性病变的相关性更高,比例为3:1。